Definitive Contract W81XWH17C0142
Award Date
9/25/17
Potential Completion Date
2/24/20
Potential Value
$1M
Federal Agency
Medical Command
Awardee
Cytosorbents Medical Inc.
Ultimate Awardee
Cytosorbents Corporation
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN91 - R&D- Medical: Other (Basic Research)
Federal Contract Vehicle
Set-Aside Type
Partial Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price Level of Effort
Place of Performance
Monmouth Junction, South Brunswick Township, NJ 08852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
135
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $999,996.59 firm-fixed-price Phase II SBIR contract awarded by the Joint PEO Chemical and Biological Defense to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for research and prototype development services related to Cytosorbents' blood purification technologies, including an extracorporeal cytokine adsorber, a potassium adsorber, and a blood group antibody adsorber. These technologies are intended to treat critical care...
Cytosorbents Medical Inc., doing business as Cytosorbents, was awarded a $999,070.00 Small Business Innovation Research (SBIR) Phase II contract by the Department of the Army Medical Command. The contract is for the development of medical devices and technologies, including an extracorporeal cytokine adsorber to treat septic shock, a potassium adsorber to treat hyperkalemia, and an adsorber to remove anti-A and anti-B antibodies from blood for transfusion. Cytosorbents is the prime contractor...
This federal contract award, with a ceiling value of $149,927.17, was issued by the U.S. Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for a SBIR Phase I research project under the Defense Health Program (DHP), with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business set-aside, Cytosorbents is the prime contractor responsible for conducting the research to...
This is a $149,979 firm-fixed-price Definitive Contract awarded by the United States Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract was awarded under the Small Business Innovation Research (STTR) program for Phase I research, with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business, this contract award was set aside for Cytosorbents as the prime...
Cytosorbents Medical Inc., doing business as Cytosorbents, was awarded a $2.9 million firm fixed price contract from the Department of the Army Medical Command to develop a highly efficient adsorber to remove anti-A and anti-B antibodies from blood and plasma for transfusion under a Small Business Technology Transfer Research Phase III solicitation. This definitive contract is a follow-on to previous STTR research awards and will support Cytosorbents' continued medical research and development...
The Department of the Army Medical Command awarded a $4.3 million firm fixed price Small Business Innovation Research Program Phase III research and development contract to Cytosorbents Medical Inc., doing business as Cytosorbents, for integrating isoagglutinin reduction for a universal dried plasma product for battlefield and first responder use. Cytosorbents Corporation, doing business as Cytosorbents, is the parent company of the prime contractor Cytosorbents Medical Inc. The work will be...
This $1.1 million firm fixed price contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, to support research and development of an adsorber to remove anti-A and anti-B antibodies from plasma for transfusion under the Small Business Innovation Research (SBIR) Program Phase II solicitation. As a total small business set-aside, the contract aims to further the prime contractor's development of an effective adsorber that...
Cytosorbents Medical Inc., doing business as Cytosorbents and classified as a small disadvantaged business, has been awarded a $74,918 firm fixed price purchase order by the Department of the Air Force Materiel Command Research Laboratory. The contract is set aside for total small business and involves research and development of a novel sorbent technology for the rapid treatment of acute joint injury and inflammation under the Small Business Innovation Research Program Phase I. Work will be...
This is a $1,499,987.16 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) program. The contract is for medical research and development to investigate a potassium adsorber for treating hyperkalemia resulting from traumatic injury and acute kidney injury in austere environments. This is a Phase II SBIR action with a completion date of February 20,...
This is a $999,877.89 Cost Plus Fixed Fee contract awarded by the Defense Health Agency to CFD Research Corporation, a small business, under the SBIR Phase II program. The contract is titled "Systems Biology Based Tools for Modeling Platelet Storage Lesion for Optimal Blood Transfusion" and is focused on developing computational tools to model platelet storage for improved blood transfusion. CFD Research Corporation is a small business specializing in engineering simulations and...